John Stofko, MPH

Associate Professor of Pharmaceutical and Health Economics · USC School of Pharmacy

A healthcare industry executive with 30+ years of diverse experiences in biopharmaceutical clinical development.

Biopharmaceutical Clinical Development Biotech/Pharmaceutical Healthcare Consulting Executive Leadership Sales and Marketing

Edik Rafailov

Professor (Research), AIPT · Aston University

Prof Rafailov current research interests include CW and ultrashort-pulse lasers; generation of light from UV to THz and biomedical photonics

Biomedical Photonics Nanostructures Ultrashort-Pulse Lasers Photonics THz Radiation

Prof. Roman Prymula

Director · University Hospital, University of Defence

Dr. Prymula is involved in various research activities in preventive medicine, including clinical development of new vaccines

Vaccination COVID-19 Infectious Diseases Vaccines Medical Microbiology

Dr. Jean-Pierre Michel

Professor of Geriatric Medicine · Geneva University

Dr. Jean-Pierre Michel is a full Professor of Medicine at Geneva University Medical School and head of the geriatric ward

Vaccination Adult Vaccination Geriatric Medicine Public Palliative Medicine Vaccines 4 Life Program

Susan Bain, DRSc

Assistant Professor of Regulatory and Quality Sciences · USC School of Pharmacy

Susan Bain is an accomplished quality and regulatory professional with experience in the medical device and pharmaceutical industries.

Regulatory and Quality Sciences Biotechnology Industries Pharmaceutical Medical Devices

Stephen Mayfield

Director, California Center for Algae Biotechnology Co-director, Food & Fuel for the 21st Century Professor · UC San Diego

Stephen Mayfield's research analyses the structures and proteins in algae.

Pharmaceuticals Biofuel Algae Molecular Genetics Protein Biochemistry

Dr. Mine Durusu-Tanriover

Professor of Internal Medicine · Hacettepe University

Prof Mine Durusu Tanriover works closely with regional and global scientific community on adult vaccination, influenza and COVID-19.

Acute Care Quality Improvement Vaccines 4 Life Program Influenza Vaccination

James K. Ferri, Ph.D.

Professor and Associate Chair, Department of Chemical and Life Science Engineering · VCU College of Engineering

Dr. Ferri is a Professor in the Department of Chemical and Life Science Engineering at VCU

Advanced Manufacturing Stability in disperse systems Interfacial Phenomena Process intensification

Seth Seabury, PhD

Associate Professor of Pharmaceutical and Health Economics · USC School of Pharmacy

Seth Seabury is an expert in the impact of health on productivity and the law impact delivery of care and patient outcomes.

Value of Innovative Treatments Pharmaceutical and Health Economics Health Care Policy Delivery of Care and Patient Outcomes Medical Care Spending

Shawn (Sheng-Chieh) Chen

Assistant Professor, Department of Mechanical and Nuclear Engineering · VCU School of Engineering

Shawn's research interests include airborne and liquid-borne nanoparticle filtration, NanoEHS, and indoor and urban air pollution control.

CFD simulation Indoor Air Quality Aerosol sampling and instrumentation Air pollution control Nanofiltration and ultrafiltration

Wujie Zhang, Ph.D.

Associate Professor · Milwaukee School of Engineering

Dr. Wujie Zhang is an expert in biomaterials, tissue engineering, stem cell-based medicine, micro/nanotechnology, and drug delivery.

Biomaterials Regenerative Medicine and Tissue Engineering Micro/Nano-technology Drug Delivery Stem Cell Research

Terri Corbo, Pharm.D., MHCDS, FASHP

Senior Vice President of Clinical Essential Services · ChristianaCare

Terri Corbo is an expert in pharmacy and value-driven healthcare operations.

Healthcare Operations Pharmacy Services Clinical Essential Services Clinical Pharmacy

Stan Gee Louie, PharmD

Professor of Clinical Pharmacy & Director of Clinical Experimental Therapeutics Program · USC School of Pharmacy

Stan Gee Louie is a clinical and translational pharmacologist with three decades of clinical and drug development experience.

Accelerating wound healing properties Developing novel drug therapy to inhibit chronic inflammation in cancer, diabetes, and neurodegenerative disease. Drug development targeting viral infection and cancer. Metabolomic approaches to dissecting the molecular mechanism(s) driving pharmacologic responses.

Seema Nagpal

Epidemiologist and Senior Leader, Public Policy · Diabetes Canada

Seema Nagpal is an epidemiologist with broad experience in research and policy

Diabetes Epidemiology Strategic Planning Clinical Research Program Evaluation

Dr Afzal-Ur-Rahman Mohammed

Professor, Pharmacy · Aston University

Afzal-Ur-Rahman Mohammed's research interests include formulation development and optimization of orally disintegrating tablets.

Dry Particle Coating Technology Tablets Pharmacy Pharmaceuticals Stability Testing

Tani Chen

Patent Attorney · Wolf Greenfield

Tani Chen counsels clients in IP protection across a variety of areas including nanotechnology, chemical processes, and analytical devices.

Pharmaceutical Chemical & Materials Technologies Intellectual Property Protection Intellectual Property Biotechnology

Lisa Holle, Pharm.D., BCOP, FHOPA

Associate Clinical Professor of Pharmacy Practice · University of Connecticut

Dr. Holle’s clinical research focuses on medical marijuana, oral cancer therapy management, and impact of clinical pharmacy services

MyDispense Medical Marijuana Pain Cancer Cancer Therapeutics

Paul Jansen

Consultant, Board Member and Advisor · Haselmeier Group

Paul Jansen is an experienced pharmaceutical industry professional with expertise in drug and biologics device development.

Biotechnology Pharmaceutical Industry Drug Development Biologics Device Development Product Launch

Frank Baumgartner, Ph.D.

Richard J. Richardson Distinguished Professor, Department of Political Science, College of Arts and Sciences · UNC-Chapel Hill

Research: public policy, agenda-setting, interest groups in American politics, the death penalty and racial profiling in traffic stops.

Race and Profiling Public Policy Death Penalty Interest groups in American politics Agenda-setting

Gerry Brunk

Managing Director · Lumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business Strategy Medical Devices Pharmaceutical Industry Drug Development Commercialization